Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Electrophysiological alterations in heart failure.

L Storstein1

  • 1Division of Clinical Pharmacology and Toxicology, Ullevaal Hospital, University of Oslo, Norway.

European Heart Journal
|August 1, 1989
PubMed
Summary

Heart failure patients frequently experience cardiac arrhythmias. Certain drug therapies, like isosorbide dinitrate/hydralazine, may reduce sudden cardiac death, offering new avenues for treatment and improved prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quality of life in hypertensive patients treated with either carvedilol or enalapril.

Blood pressure·1996
Same author

Electrophysiological impact of diuretics in heart failure.

British heart journal·1994
Same author

[Potassium channel openers. A new possible therapeutic principle in several diseases].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·1994
Same author

Ambulatory electrocardiographic findings in top athletes, athletic students and control subjects.

Cardiology·1994
Same author

Electrocardiographic findings of repolarization in athletic students and control subjects.

Cardiology·1994
Same author

Carvedilol--a wide therapeutic potential in cardiovascular syndromes. Introduction.

Cardiology·1993

Area of Science:

  • Cardiology
  • Cardiac Electrophysiology

Background:

  • Electrophysiological defects are common in heart failure, leading to diverse cardiac arrhythmias.
  • Arrhythmias can be triggered by mechanical factors, catecholamines, ischemia, or drug-induced hypokalemia.
  • Ventricular and supraventricular arrhythmias, including atrial fibrillation, are highly prevalent, especially in NYHA class IV patients.

Purpose of the Study:

  • To explore the role of arrhythmias in heart failure prognosis.
  • To investigate the efficacy of specific drug therapies in reducing mortality.
  • To identify improved strategies for cardiac rhythm control in heart failure.

Main Methods:

  • Review of existing literature and clinical trial data.
  • Analysis of arrhythmia prevalence and characteristics in heart failure patients.
  • Comparison of mortality outcomes between different therapeutic interventions.

Main Results:

  • Combined isosorbide dinitrate and hydralazine therapy reduced mortality from sudden death or pump failure, outperforming prazosin.
  • Enalapril lowered pump failure mortality compared to placebo but did not impact sudden death incidence.
  • Complex ventricular arrhythmias and non-sustained ventricular tachycardia are prognostic markers, but their direct role in sudden death initiation requires further proof.

Conclusions:

  • Therapeutic strategies targeting specific mechanisms, such as combined isosorbide dinitrate/hydralazine, show promise in reducing sudden cardiac death in heart failure.
  • Further research is needed to elucidate the precise role of arrhythmias in heart failure progression and sudden death.
  • Improved understanding of arrhythmia mechanisms may lead to better cardiac rhythm management and enhanced patient prognosis.

Related Experiment Videos